This pocket guide is intended to be a resource for physicians and other health care professionals who provide care and treatment to patients with MDR TB in DOTS-Plus projects.
This guideline is developed by the Global Health Initiative, World Health Organization, UNAIDS and the Global Partnership to Stop TB for the joint management of HIV/AIDS and TB in the workplace.
This book presents five papers that were used as background to a workshop on "Improving TB Drug Management: Accelerating DOTS Expansion" on June 2002, in Washington, DC. The papers address the weaknesses in drug management programs of certain countries and provide a framework for strengthening these programs through country-specific action plans.
This report provides suggestions that may facilitate increased involvement of the National Tuberculosis Control Program (NTP) in health sector reform, encourage increased technical input into health systems' planning, and promote the strategic positioning of TB control in the context of changing health systems.
This guideline promotes collaboration between TB and HIV/AIDS programs to reduce the burden for people affected by both diseases.
This report assesses the effectiveness, cost, and cost-effectiveness of the public-private mix DOTS (PPM-DOTS) program in pilot projects in Hyderabad and Delhi, India.
This guideline sets forth the framework to guide European countries in developing their national plan for reducing TB/HIV morbidity and mortality. The framework sets out the rationale for effective collaboration between HIV/AIDS and tuberculosis national programs.
This report explains the European DOTS Expansion plan to control TB. The plan highlights country needs and resource gaps, emphasizing collaboration with the governments of endemic countries, national and international agencies, and nongovernmental organizations (NGOs). The aim is to stimulate social and political commitment to achieving the global TB targets as part of the overall health system. The plan is based on two principles: the development of national DOTS expansion plans and partnership-building to control TB.
This group of four fact sheets explain the origin and purpose of the Global Drug Facility (GDF), how the GDF works, how to apply to the GDF for a grant of TB drugs, and how to buy drugs through the GDF.
This prospectus is a culmination of input from Stop TB Partners including representatives from TB high-burden countries, UN agencies, Nongovernmental Organizations (NGOs), and foundations to develop the form, strategies, objectives, and governance of the Global TB Drug Facility (GDF).
